Funds · LCTX

Who owns LCTX?

Institutional ownership of Lineage Cell Therapeutics Inc. from Form 13F, Q2 2026

130 institutional managers reported holding Lineage Cell Therapeutics Inc. (LCTX) in Form 13F filings for Q2 2026, with 66,959,986 shares worth $87.7M. The largest reported holder was BlackRock, Inc. Managers that filed both quarters added a net 4,831,645 shares (+7.8%). 33 opened new positions and 33 sold out.

Funds holding
130
Value held
$87.7M
New / sold out
33 / 33
Net shares, same filers
+7.8%

Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

Largest holders of LCTX

FundValueShare of 13F holdingsSharesMove
BlackRock, Inc.$17.3M19.7%13,186,895Added
Vanguard Capital Management LLC$11.9M13.5%9,054,918Added
Defender Capital, LLC.$8.6M9.9%6,598,899Trimmed
Geode Capital Management, LLC$6.9M7.9%5,299,457Added
Raffles Associates LP$6.8M7.8%5,197,788Trimmed
Fifth Third Bancorp$6.0M6.9%4,600,000Unchanged
Millennium Management LLC$4.0M4.5%3,018,567Trimmed
State Street Corp$3.0M3.5%2,314,180Added
Vanguard Fiduciary Trust Co$2.2M2.5%1,668,629Added
Northern Trust Corp$2.2M2.5%1,656,651Added
Morgan Stanley$1.9M2.2%1,471,462Trimmed
Renaissance Technologies LLC$1.8M2.0%1,344,829Trimmed
Marshall Wace, LLP$1.7M1.9%1,282,347Trimmed
Vanguard Portfolio Management LLC$1.7M1.9%1,273,311New
UBS Group AG$900K1.0%687,051Trimmed
Red Crane Wealth Management, LLC$782K0.9%597,263Unchanged
Charles Schwab Investment Management Inc$756K0.9%577,435Added
Barclays PLC$666K0.8%508,668Added
Squarepoint Ops LLC$583K0.7%444,774Added
Goldman Sachs Group Inc$568K0.6%433,266Trimmed
Citadel Advisors LLC$558K0.6%426,169Added
Bank of America Corp$556K0.6%424,373Added
Bank of New York Mellon Corp$513K0.6%391,675Added
Flputnam Investment Management Co$399K0.5%304,562New
Nuveen, LLC$321K0.4%245,384New

Share of 13F holdings is each fund's shares as a share of the 66,959,986 LCTX shares all 13F filers reported, not of shares outstanding.

The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $27.0M and sold $22.4M; 25 added and 29 trimmed.

Schedule 13D and 13G filings on LCTX

Owners of more than 5% must file within days, so these can be newer than the 13F data.

Questions about LCTX ownership

Who owns LCTX stock?
130 institutional investment managers reported LCTX positions in their Form 13F filings for Q2 2026, holding 66,959,986 shares worth $87.7M in total. BlackRock, Inc. reported the largest position.
Are funds buying or selling LCTX?
In Q2 2026, 33 managers opened new LCTX positions, 25 added, 29 trimmed and 33 sold out. Managers that filed in both quarters added a net 4,831,645 shares.
How current is this LCTX institutional ownership data?
It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.

From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to LCTX by CUSIP. Options are left out. LCTX news and filings · LCTX insider trades · Top funds